Highest-materiality recent filing
TruBridge Q1 revenue $86.3M, flat YoY; reaffirms pending $26.25/share acquisition by IKS Health
Total bookings $17.7M vs $17.3M; revenue $86.3M vs $87.2M; recurring revenue 94%.
TruBridge to be acquired by IKS Health for $26.25/share in cash
Per share cash consideration of $26.25; support agreements cover ~27% of outstanding TruBridge common stock.
TruBridge Q4 revenue $87.2M, full-year GAAP net income $4.4M; engages strategic review
Q4 revenue $87.2M (down 1% YoY); bookings $19.8M (+38% YoY); recurring revenue 94%.
TruBridge appoints Pinetree President Damien Leonard to board; three directors to retire by 2027
Damien Leonard (Pinetree President) joins TruBridge Board Jan 12; board expands to 10, then shrinks to 7 after 2026 annual meeting.
Revolver capacity increased to $180M (from $160M); term loan outstanding now $70M (up from $54M).
TruBridge Q3 2025: Revenue $86.1M, GAAP net income $5.6M, Adj EBITDA $16.3M, raises guidance
Total revenue $86.1M, up 1.7% YoY; recurring revenue 94% of total; Financial Health segment $54.5M (63% of revenue).
TruBridge: CSO Dawn Severance to depart Oct 31; Michael Daughton hired as Chief Business Officer
CSO Dawn Severance will leave Oct 31, 2025; position eliminated; no disagreement cited.
Total revenue $85.7M flat YoY; recurring revenue 95%. Financial Health segment $54.3M.
TruBridge dismisses Grant Thornton, appoints KPMG; prior adverse internal control opinions
Audit Committee dismissed Grant Thornton LLP as auditor, effective June 25, 2025.
TruBridge shareholders approve board declassification and incentive plan increase at annual meeting
Stockholders approved declassification of Board, effective 2026 annual meeting; filed with Delaware on May 8, 2025.
TruBridge Q1 beats with $87.2M revenue & $18.2M adj. EBITDA; raises FY outlook
Revenue of $87.2M grew 3.7% YoY; GAAP net income $0.5M vs. $1.9M loss; non-GAAP net income $5.2M vs. $3.4M.
TruBridge corrects revenue error, revises FY2024 net loss to -$20.4M from -$23.1M
Revenue for FY24 revised up $3.5M to $342.6M; FY23 revised down $3.5M to $335.9M.
TruBridge reports FY2024 revenue $339.2M, net loss $23.1M; issues FY2025 guidance
Q4 2024 revenue $87.4M (up 1.7% YoY); adjusted EBITDA $17.2M vs $12.0M YoY.
TruBridge adds two directors, declassifies board in cooperation deal with top investors
Appointed Jerry Canada (former Group President, Harris Computer Healthcare) and Dris Upitis (Head of Ocho) as independent Class II directors, increasing board from 7 to 9.
TruBridge COO David A. Dye departs effective Dec 31, 2024; receives severance package
David A. Dye ceases as Chief Operating Officer effective December 31, 2024.
TruBridge Q3 revenue $83.8M, bookings $21M; COO David Dye retiring
Q3 revenue $83.8M vs $82.7M YoY; bookings $21.0M (up 40% from $15.0M).
TruBridge amends bylaws to update proxy card rules, definitions, and officer duties
Board approved Second Amended and Restated Bylaws effective October 25, 2024.
TruBridge appoints Amy O'Keefe to board, replacing Denise Warren effective Nov 15, 2024
Denise Warren resigns from TruBridge board effective Nov 15, 2024 to become chair of Brookdale Senior Living (NYSE: BKD).
TruBridge Q2 revenue flat at $84.7M, adjusted EBITDA up to $12.6M, reaffirms FY guidance
Total revenue $84.7M vs $84.6M; RCM revenue grew 13% to $54.1M (63.9% of total).
TruBridge stockholders re-elect directors, approve say-on-pay and auditor at 2024 annual meeting
Class I directors Mark V. Anquillare and Glenn P. Tobin re-elected to serve until 2027.
TruBridge Q1: GAAP loss of $0.17/share; FY2024 revenue guidance lowered
Total revenue $83.2M (-3.5% YoY); RCM revenue grew to $53.0M (63.7% of total).
TruBridge amends poison pill, raises triggering threshold to 15% from 10% after stockholder input
Board approved amendment to Rights Plan increasing beneficial ownership threshold from 10% to 15%.
On November 7, 2024, TruBridge, Inc. (the “Company”) announced that David A. Dye will no longer serve as the Company’s Chief Operating Officer, effective December 31, 2024.
On November 1, 2024, TruBridge, Inc. (the “Company”) and David A. Dye, the Company’s Chief Operating Officer and a director of the Company, agreed that Mr. Dye will no longer serve as the Company’s Chief Operating Officer, effective December 31, 2024.
On October 18, 2024, Denise W. Warren submitted her resignation from the Board of Directors (the “Board”) of TruBridge, Inc. (the “Company”), effective November 15, 2024.
Also on October 18, 2024, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, the Board elected Amy O’Keefe, effective immediately, to fill the seat on the Board that will be vacated by Ms. Warren.
Max materiality 1.00 · Median 0.65 · Most common event earnings